Investors

Financials & Filings

Document Details

Form
Filing Date
Oct 17, 2025
Document Date
Oct 15, 2025
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Xenon Pharmaceuticals Inc.
Issuer
Xenon Pharmaceuticals Inc.
Filer
Kelly Thomas Patrick

Investor inquiries

Tucker Kelly 
Chief Financial Officer
investors@xenon-pharma.com
 

Email alerts

Sign up here to receive email alerts from Xenon Pharmaceuticals